Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

558 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.
Sun CQ, Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Srinivasan M, Raghavan A, O'Brien KS, Ray KJ, McLeod SD, Porco TC, Acharya NR, Lietman TM. Sun CQ, et al. Among authors: mascarenhas j. Invest Ophthalmol Vis Sci. 2013 Jun 14;54(6):4167-73. doi: 10.1167/iovs.13-11716. Invest Ophthalmol Vis Sci. 2013. PMID: 23702779 Free PMC article. Clinical Trial.
Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.
Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Oldenburg CE, Ray KJ, Glidden D, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Sy A, et al. Among authors: mascarenhas j. Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):267-72. doi: 10.1167/iovs.11-7840. Invest Ophthalmol Vis Sci. 2012. PMID: 22159005 Free PMC article. Clinical Trial.
The clinical differentiation of bacterial and fungal keratitis: a photographic survey.
Dalmon C, Porco TC, Lietman TM, Prajna NV, Prajna L, Das MR, Kumar JA, Mascarenhas J, Margolis TP, Whitcher JP, Jeng BH, Keenan JD, Chan MF, McLeod SD, Acharya NR. Dalmon C, et al. Among authors: mascarenhas j. Invest Ophthalmol Vis Sci. 2012 Apr 2;53(4):1787-91. doi: 10.1167/iovs.11-8478. Invest Ophthalmol Vis Sci. 2012. PMID: 22395880 Free PMC article. Clinical Trial.
Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis.
Oldenburg CE, Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Mascarenhas J, Nardone N, Ray KJ, Glidden DV, Acharya NR, Lietman TM. Oldenburg CE, et al. Among authors: mascarenhas j. Invest Ophthalmol Vis Sci. 2013 Feb 28;54(2):1522-6. doi: 10.1167/iovs.12-11246. Invest Ophthalmol Vis Sci. 2013. PMID: 23385795 Free PMC article. Clinical Trial.
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M, Raghavan A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Porco TC, Acharya NR, Lietman TM; Mycotic Ulcer Treatment Trial Group. Prajna NV, et al. Among authors: mascarenhas j. JAMA Ophthalmol. 2013 Apr;131(4):422-9. doi: 10.1001/jamaophthalmol.2013.1497. JAMA Ophthalmol. 2013. PMID: 23710492 Free PMC article. Clinical Trial.
The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.
Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, O'Brien KS, Glidden DV, Ray KJ, Oldenburg CE, Zegans ME, Whitcher JP, McLeod SD, Porco TC, Lietman TM, Acharya NR; Steroids for Corneal Ulcers Trial Group. Srinivasan M, et al. Among authors: mascarenhas j. Am J Ophthalmol. 2014 Feb;157(2):327-333.e3. doi: 10.1016/j.ajo.2013.09.025. Epub 2013 Oct 1. Am J Ophthalmol. 2014. PMID: 24315294 Free PMC article. Clinical Trial.
Visual recovery in treated bacterial keratitis.
Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Ray KJ, Zegans ME, Acharya NR, Lietman TM, Keenan JD; Steroids for Corneal Ulcers Trial Group. Srinivasan M, et al. Among authors: mascarenhas j. Ophthalmology. 2014 Jun;121(6):1310-1. doi: 10.1016/j.ophtha.2013.12.041. Epub 2014 Mar 5. Ophthalmology. 2014. PMID: 24612976 Free PMC article. Clinical Trial.
Visual outcomes in treated bacterial keratitis: four years of prospective follow-up.
McClintic SM, Prajna NV, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Oldenburg CE, O'Brien KS, Ray KJ, Acharya NR, Lietman TM, Keenan JD. McClintic SM, et al. Among authors: mascarenhas j. Invest Ophthalmol Vis Sci. 2014 May 2;55(5):2935-40. doi: 10.1167/iovs.14-13980. Invest Ophthalmol Vis Sci. 2014. PMID: 24618327 Free PMC article. Clinical Trial.
Early addition of topical corticosteroids in the treatment of bacterial keratitis.
Ray KJ, Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Glidden DV, Oldenburg CE, Sun CQ, Zegans ME, McLeod SD, Acharya NR, Lietman TM. Ray KJ, et al. Among authors: mascarenhas j. JAMA Ophthalmol. 2014 Jun;132(6):737-41. doi: 10.1001/jamaophthalmol.2014.292. JAMA Ophthalmol. 2014. PMID: 24763755 Free PMC article. Clinical Trial.
Trends in bacterial and fungal keratitis in South India, 2002-2012.
Lalitha P, Prajna NV, Manoharan G, Srinivasan M, Mascarenhas J, Das M, D'Silva SS, Porco TC, Keenan JD. Lalitha P, et al. Among authors: mascarenhas j. Br J Ophthalmol. 2015 Feb;99(2):192-4. doi: 10.1136/bjophthalmol-2014-305000. Epub 2014 Aug 20. Br J Ophthalmol. 2015. PMID: 25143391 Free PMC article.
558 results